MedPath

Improving Aspirin Prescription Rates in Outpatient Clinic

Recruiting
Conditions
Low Birth Weight
Small for Gestational Age (SGA)
Preeclampsia (PE)
Prevention &Amp; Control
Interventions
Registration Number
NCT06694233
Lead Sponsor
Cairo University
Brief Summary

Ρrееςlаmpѕia is a syndrome characterised by the new onset of hуреrtеnѕion plus proteinuria, end-organ dysfunction, or both after 20 weeks of gestation. It complicates 3-5% of pregnancies.

Low-dose aspirin reduces the frequency of рrееςlampsia, as well as related adverse рrеgոaոcy outcomes (preterm birth, growth restriction), by 10 to 70% when taken by patients аt moderate to high risk of the disease. It has an excellent maternal/fetal safety profile. Thus, it is a reasonable preventive strategy for these patients.

A pilot study at our hospital found that not all patients who are candidates for aspirin prescription receive it (only 40%). This audit cycle aims to increase aspirin prescription rates for moderate and high-risk obstetric populations.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
300
Inclusion Criteria

Women at high risk are those with any of the following:

  1. hypertensive disease during a previous pregnancy
  2. chronic kidney disease
  3. autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome
  4. type 1 or type 2 diabetes
  5. chronic hypertension.

Women with more than one moderate risk factor, such as are:

  1. nulliparity
  2. age 40 years or older
  3. pregnancy interval of more than 10 years
  4. body mass index (BMI) of 35 kg/m2 or more at first visit
  5. family history of pre-eclampsia
  6. multi-fetal pregnancy.
Exclusion Criteria
  • None. All eligible candidates will be included.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Obstetric population candidate for aspirin prescriptionAspirin prescription on outpatient basisModerate- and high-risk obstetric population
Primary Outcome Measures
NameTimeMethod
Aspirin prescriptionSix months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Adan hospital

🇰🇼

Hadiya, Ahmadi, Kuwait

© Copyright 2025. All Rights Reserved by MedPath